Preparation and Characterization of Poly(lactide-co-glycolide) Micro-spheres for the Sustained Release of AZT

  • Gilson Khang (Department of Polymer Science and Technology, Chonbuk National University) ;
  • Lee, Jin-Ho (Department of Polymer Science and Engineering, Hannam University) ;
  • Lee, Jin-Whan (Biomaterials Laboratory, Korea Research Institutes of Chemical Technology) ;
  • Cho, Jin-Cheol (Biomaterials Laboratory, Korea Research Institutes of Chemical Technology) ;
  • Lee, Hai-Bang (Biomaterials Laboratory, Korea Research Institutes of Chemical Technology)
  • 발행 : 2000.04.01

초록

Biodegradable microspheres were prepared with poly(L-lactide-co-glycolide) (PLGA, 75 : 25 by mole ratio) by an oil/oil solvent evaporation method for the sustained release of anti-AIDS virus agent, AZT The microspheres of relatively narrow size distribution (7.6$\pm$ 3.8 ㎛) were obtained by controlling the fabrication conditions. The shape of microspheres prepared was smooth and spherical. The efficiency of AZT loading into the PLGA microsphere was over 93% compared to that below 15% for microspheres by a conventional water/oil/water method. The effects of Preparation conditions on the morphology and in vitro AZT release pattern were investigated. in vitro release studies showed that different release pattern and release rates could be achieved by simply modifying factors in the fabrication conditions such as the type and amount of surfactant, initial amount of loaded drug, the temperature of solvent evaporation, and so on. PLCA microspheres prepared by 5% of initial drug loading, 1.0% (w/w) of surfactant concentration, and 25$\^{C}$ of solvent evaporation temperature were free from initial burst effect and a near-zero order sustained release was observed. Possible mechanisms of the near-zero order sustained release for our system have been proposed.

키워드

참고문헌

  1. J. Am. Med. Assoc. v.258 no.1517 I. Brook
  2. Eur. J. Haematol. v.47 no.91 F. P. R. Chow;A. W. Hamburger
  3. Ann. Inter. Med. v.106 no.568 V. T. Devita;S. Broder;A. S. Fauci;J. A. Kovacs;B. A. Chabner
  4. Clin, Pharmacol, Ther. v.41 no.407 R. Klecker;J. Collins;R. Yarchoan;R. Thomas;J. F. Jenkins;S. Border;C. E. Meyers
  5. Am. J. Hematol v.35 no.1 J. D. Lutton;A. Mathew;R. D. Lervere;N. G. Abraham
  6. Polymer (Korea) v.20 no.347 S. Y. Jeong;J. H. Lee;S. H. Yuk;H. B. Lee
  7. J. Control. Rel. v.51 no.161 S. Y. Oh;S. Y. Jeong;T. G. Park;J. H. Lee
  8. In Drugs and Pharmaceutical Science v.45 Biodegradable polymers as drug delivery systems O. H. Lewis;M. Cashin(eds.);R. Langer(eds.)
  9. Korea Polymer J. v.7 no.79 J. C. Cho;G. Khang;J. M. Rhee;Y. S. Kim;J. S. Lee;H. B. Lee
  10. Bio-Med. Mater. Eng. v.9 no.49 G. Khang;J. C. Cho;J. W. Lee;J. M. Rhee;H. B. Lee
  11. Polymer Preprint v.40 no.288 H. B. Lee;G. Khang;J. C. Cho;J. M. Rhee;J. S. Lee
  12. ACS Boook Series, ACS symposium for Toward 21st Century-Drug Delivery System G. Khang;J. C. Cho;J. M. Rhee;J. S. Lee;H. B. Lee
  13. Int. J. Pharm. v.98 no.157 P. Sandrap;A. J. Moes
  14. J. Control. Rel. v.35 no.91 C. George;T.G. Park
  15. Int. J. Pharm. v.89 no.235 C. Sturesson;J. Carlfors;K. Edman;M. Anderson
  16. Chem. Pharm. Bull. v.36 no.1294 Y. Ogawa;M. Yamamoto;H. Okada;T. Yashiki;T. Yamamoto
  17. Fertil. Steril. v.31 no.545 L. R. Beck;D. R. Cowsar;D. H. Lewis;R. J. Cosdrove;S. L. :owry;T. Epperly
  18. Pharm. Sci. v.1 no.367 T. K. Mandal;S. Tenjarla
  19. J. Microencapsul. v.13 no.257 T. K. Mandal;A. Lopez-Anaya;E. Onyebueke;M. Shekleton
  20. J. Maicroencapsul. v.13 no.545 T. K. Mandal;M. Shekleton;E. Onyebueke;L. Washington;T. Penson
  21. Int. J. Pharm. v.137 no.187 T. K. Mandal;S. Tenjarla
  22. Pharm. Sci. v.2 no.99 T. K. Mandal
  23. J. Control. Rel. v.17 no.41 T. Seki;T. Kawaguchi;K. Juni;K. Sagibayashi;Y. Morimoto
  24. J. Microencapsul. v.7 no.347 R. Alex;R. Bodmeier
  25. J. Control. Rel. v.32 no.161 C. Schugens;N. Laurelle;N. Nihant;C. Grandfils;R. Jerome;P. Teyssie